SCHEMBL25818647

SCHEMBL25818647

OBOc1ccc2c(ccc3c4ccccc4ccc23)c1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPRT1 P00492 4/20 0.50
ALDH1A1 P00352 4/20 0.47
HSD17B10 Q99714 3/20 0.47
CYP1B1 Q16678 2/20 0.47
HIF1A Q16665 1/20 0.47
HPGD P15428 2/20 0.46
MAPT P10636 1/20 0.46
CYP2A6 P11509 2/20 0.43
TSHR P16473 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
TRPM4 Q8TD43 1/20 0.42
CYP1A2 P05177 4/20 0.39
ERBB2 P04626 1/20 0.39
FYN P06241 1/20 0.39
MAOA P21397 1/20 0.39
ACHE P22303 1/20 0.39
AHR P35869 1/20 0.39
CYP1A1 P04798 1/20 0.39
PAX8 Q06710 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17752309 0.98 ALDH1A1 (0.48) HPRT1ALDH1A1HSD17B10CYP1B1HIF1A
SCHEMBL25608351 0.90 CYP1A2 (0.41) HPRT1ALDH1A1HSD17B10CYP1B1HIF1A
SCHEMBL25818597 0.89 ALDH1A1 (0.50) HPRT1ALDH1A1HSD17B10CYP1B1HIF1A
SCHEMBL10252075 0.88 CYP11B1 (0.42) HPRT1ALDH1A1HSD17B10CYP1B1HIF1A
SCHEMBL10251735 0.86 CYP11B1 (0.41) HPRT1ALDH1A1HSD17B10CYP1B1HIF1A
SCHEMBL10252062 0.85 ALDH1A1 (0.41) HPRT1ALDH1A1HSD17B10CYP1B1HIF1A
SCHEMBL10197724 0.85 CYP11B1 (0.43) HPRT1ALDH1A1HSD17B10CYP1B1HIF1A
SCHEMBL3437809 0.85 CYP1A2 (0.52) ALDH1A1HSD17B10MAPTCYP2A6TDP1
SCHEMBL10251809 0.84 ALDH1A1 (0.40) HPRT1ALDH1A1HSD17B10CYP1B1HIF1A
SCHEMBL12025700 0.83 GPR84 (0.43) ALDH1A1HSD17B10CYP1B1HIF1AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, ESR1, OR51E2 HPRT1 597/4885ALDH1A1 1010/4885HSD17B10 3433/4885
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 HPRT1 597/4885ALDH1A1 1010/4885HSD17B10 3433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.